What Is New in Psychiatry and Psychopharmacology—2nd Edition

Dear Colleagues,

The first volume of this Special Issue was a great success (https://www.mdpi.com/journal/life/special_issues/QIBPZ6UU36); therefore, we invite you to publish your research in the second volume of this Special Issue.

Psychiatry and psychopharmacology are rapidly evolving on the basis of clinical observations, therapeutic demands, biomarkers, development of novel drugs beyond classical paradigms and, last but not least, challenges from a changing world, creating novel problems in this field.

It is evident that there is a major need for more targeted and effective drugs and more focused psychological interventions able to resolve the high percentage of non-response amongst patients with different disorders. Unfortunately, the demand for innovation may clash with current economic constraints, leading to more limited resources for clinical practice and research, as well as the shift toward the management of the COVID-19 pandemic.

For these reasons, the aim of this Special Issue is to put together a collection of papers dealing with some “hot topics” in the domains of psychiatry and psychopharmacology. Indeed, this Special Issue will include contributions on bipolar disorders, obsessive compulsive disorders, post-traumatic stress disorder, depression, agitation in children, biomarkers in addiction, therapeutic strategies for resistant cases, and new applications and targets of transcranial magnetic resonance.

Prof. Dr. Donatella Marazziti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• clinical psychiatry
• biomarkers
• psychopharmacology
• addictions
• agitations
• pharmacological resistance
• transcranial magnetic resonance